Revolutionizing Water Stewardship – The City of Dire Dawa and Nedamco Africa Unveil Cutting-Edge Water Management Platform Initiative at COP28 | December 9th 2023 | COP28UAE Press Center
Today, at COP28 in the UAE, the city of Dire Dawa (Ethiopia) Water Supply and Sewerage Authority (DDWSSA) and Nedamco Africa together with its partners Microsoft, Deltares, Hulo.ai and Isle Utilities announced the launch of the “Nedamco Catchment-City-Waste Water Management” (CCW) project for the city of Dire Dawa. The CCW solution by Nedamco Africa and its partners Microsoft, Deltares and Hulo.ai is an integrated technology platform that directly addresses the critical challenges of water losses and inefficient management, prevalent in rapidly urbanizing regions like Dire Dawa. It embodies a holistic approach to water management by harnessing digital twin technology, AI/ML, and satellite imagery to deliver comprehensive monitoring of water infrastructures, detect leakages, and make climate impact predictions with the goal to provide more access to water, more water availability as well as improved water quality. With the deployment of the CCW platform Dire Dawa envisions a transformative shift in water resource stewardship, fostering a sustainable, resilient future for the inhabitants of Dire Dawa.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231209358320/en/
Dire Dawa Water Authority CEO and Nedamco Ethiopia CEO signing the agreement (Photo: Business Wire)
"We are proud to announce a pivotal project in partnership with Nedamco Africa that addresses Dire Dawa's water challenges. Through cutting-edge technology, we're ensuring accurate, verifiable improvements in water management that will significantly enhance the quality of life for our city's residents by providing more water. This initiative is not just about innovation - it's about securing a sustainable future for Dire Dawa, opening doors to new financing for vital water infrastructure, and supporting our community in meeting the critical demands of water conservation aligned with SDG6," said Mohammed Mussie, CEO of Dire Dawa Water Supply and Sewerage Authority.
A leap towards sustainable climate action financing - The innovative approach involves integrating advanced technologies with meticulous (near) real-time data collection and analysis, enabling the accurate measurement of the environmental benefits derived from water conservation efforts. In this process, Nedamco Africa utilizes cutting-edge tools from global technology leaders, leverages AI and ML models, high-resolution satellite imagery, and blockchain technologies. These tools facilitate a reliable, real-time tracking of water management and improvements, ensuring that the generated water data is not only verifiable but also transparent and scalable. Nedamco Africa leverages this approach to creating water certificates that employ the Volumetric Water Benefits Accounting (VWBA) 2.0 methodology, which allows for a comprehensive and quantifiable assessment of water management projects. By adhering to rigorous standards Nedamco Africa can guarantee the created certificates reflect genuine improvements in water management, offering an asset in the global efforts to promote sustainable water usage and management. The approach not only aids DDWSSA in effective water resource management but also opens new avenues for DDWSSA to attract innovative financing in water network development and community support, aligning closely with global sustainability goals like SDG6.
“This initiative has a huge potential to impact the lives of many. When water distribution systems become smart, they present an opportunity to market the digital proof of reduced losses from the system to companies that want to pay to compensate their water use, and in this way facilitate investment in utilities and their networks. I will keep supporting this initiative in Ethiopia where a pilot will take place in Dire Dawa and, we’re tapping into a completely new market. This will accelerate private investments in the true spirit of the Water Action Agenda of UN23 to help reach SDG6 in time. We take pride in the Netherlands' legacy of water management, transforming water challenges into opportunities for sustainable development,” said Jelmer van Veen, First Secretary for Water Affairs at Embassy of the Kingdom of the Netherlands in Ethiopia.
This public-private partnership (PPP) initiative exemplifies the transformative potential of public-private partnerships, leveraging collective expertise, resources, and innovation to foster a green economy. By blending state-led environmental programs with private sector dynamism and international climate finance mechanisms.
"We see the Dire Dawa collaboration as a cornerstone for climate resilience, marking a significant Public-Private Partnership that will lead the way for cities globally to embrace similar strategies. This key initiative showcases the practical application of advanced technologies in combating daily climate challenges, especially in water-stressed regions. It's a testament to Nedamco Africa’s commitment to not only address water scarcity but also enhance biodiversity. Our work in Dire Dawa is paving the path for more cities to join this battle against climate change, ensuring sustainable environments for future generations," stated Michael Kogeler, CEO of Nedamco Africa.
Microsoft is a pivotal partner and contributors to the initiative, providing the technological backbone and innovative solutions critical to the success of the system. Microsoft's cutting-edge cloud computing platforms and AI capabilities enable the robust processing and analysis of vast environmental data sets. Together, the collaborative efforts of the partners and DDWSSA are not only enhancing the precision of water management but are also setting a new standard in data-driven conservation and sustainable water practices on a global scale.
"We are immensely proud to be at the forefront of this transformative journey with DDWSSA and Nedamco Africa," said Anke den Ouden, CEO of Microsoft Netherlands. "By leveraging Microsoft's advanced cloud and AI technologies, we are setting a new paradigm in environmental stewardship. Our commitment to sustainability goes beyond our products; it's about empowering our partners to achieve a greener future. This collaboration is a testament to the power of technology in making a substantial impact on our planet's health and the well-being of communities across Africa."
Building local expertise in Ethiopia - The Nedamco Academy in Ethiopia stands as a cornerstone of the collaborative agreement, serving as a vital hub for water capacity building and education. The Nedamco Academy is on a mission to empower DDWSSA professionals with cutting-edge knowledge and skills in technology and water management.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231209358320/en/
Contact information
Press inquiries – info@nedamcoafrica.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 10:00:00 CET | Press Release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in
Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 10:00:00 CET | Press Release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration
Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 10:00:00 CET | Press Release
Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press Release
Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity. Pimicotinib, a colony stimulating factor-1 receptor (CSF-1R) inhibitor developed by Abbisko Therapeutics Co., Ltd., Shanghai, China, is the first Chemical Drug Class 1 approved in China for the treatment of TGCT. “We are continuing to deliver on our commitment to improving the lives of patients with rare tumors with this first-in-the-world regulatory approval of pimicotinib,” said Danny Bar-Zohar, CEO Healthcare and Member of the Executive Board of Merck. “This approval is a significant step forward in further strengthening our leadership in rare tumors, while offering patients the opportunity to change the course of
Incyte Japan Announces Approval of Minjuvi ® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press Release
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
